Skip to content
Head to head

Bruker Corp vs Abbott Laboratories

Side-by-side on the measures that matter, with a plain-English read. Full detail: BRKR · ABT

Updated 8 minutes ago

1-year performance, rebased to 100

BRKR +35.7%ABT -19.3%
Abbott Laboratories edges it on the scoreable measures. Abbott Laboratories pays the highest dividend yield; Abbott Laboratories earns the most per share.
BRKRABT
Snapshot
SectorMedical DevicesMedical Devices
Last price56.46103.00
Change today-9.08%-0.84%
1-year return+29.3%-15.4%
Market cap$8.62B$178.39B
52-week range32.26 – 68.9880.89 – 126.70
Valuation
P/E (TTM)-51.3338.29
P/E percentile, own 5-yr range20th99th
P/B3.773.50
Dividend yield0.35%2.41%
Profitability & growth
EPS (TTM)-0.153.72
Net profit (TTM)$-22.91M$6.44B
Revenue (TTM)$3.51B$48.23B
Provider revenue period date2026-09-292026-09-29
Revenue growth (YoY)+1.6%+14.5%
Gross margin47.7%56.9%
Operating margin9.5%13.8%
Net margin-4.8%9.7%
Free cash flow (TTM)$215.30M$6.76B
Provider cash-flow period date2026-09-292026-09-29
Ownership & sentiment
Institutional ownership95.3%81.2%
Insider activity (12mo)26 buy / 23 sell36 buy / 12 sell
Short interest (% of float)7.4%1.1%
Analyst consensus43% buy / 43% hold / 14% sell (7)93% buy / 7% hold (15)
Analyst price target$67 (+18%)$122 (+18%)
StockVane view
StockVane Quant RatingC (76)D (22)
Company
Employees11,085115,000
Founded19601900

▲ marks the more favourable stock(s) on measures with a clear direction (lower P/E, higher yield, higher Quant Rating, better 1-year return). Analyst consensus counts each covering institution once, at its most recent rating. Not a recommendation. Quant Rating method: Data & Methodology.